Kahan Packaging Reports FY26 Revenue of Rs 30.47 Cr; Bonus Allotted

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Kahan Packaging Reports FY26 Revenue of Rs 30.47 Cr; Bonus Allotted

Kahan Packaging Ltd has announced its financial results for FY26, reporting a rise in total income to Rs 30.47 crore and a PAT of Rs 1.17 crore. The company also completed a 3:1 bonus share allotment in August, signaling management confidence. While revenue growth remains steady, the firm faces challenges from raw material price volatility and market competition.

Kahan Packaging FY26 Revenue Rises to Rs 30.47 Crore

Total income for the year ended March 31, 2026, hit Rs 30.47 crore, up from Rs 28.52 crore in the previous fiscal. Profit after tax (PAT) rose to Rs 1.17 crore from Rs 1.12 crore, with earnings per share (EPS) improving to 4.30.

Reader Takeaway: Strong revenue and a 3:1 bonus issue are offset by raw material price volatility and competition.

What just happened

Kahan Packaging concluded the 2025-26 fiscal year with improved financial metrics. Beyond the earnings growth, the company completed a significant capital restructuring. Following an August 12, 2026, postal ballot approval, the board allotted bonus equity shares in a 3:1 ratio on August 21, 2026. This move expanded the paid-up share capital to Rs 10.88 crore, while the authorized share capital was scaled to Rs 15 crore.

Why this matters

The steady increase in PAT and the issuance of bonus shares generally signal that management is comfortable with the company’s liquidity and long-term equity position. For investors, this adjustment effectively increases the number of shares held, though it dilutes per-share value proportionally.

Risks to watch

Management explicitly identified several operational hurdles that could pressure margins in the coming quarters. These include the volatility of raw material prices and potential supply chain disruptions. Furthermore, the company noted that intense competition in the packaging sector may limit its ability to pass cost increases on to customers, potentially impacting the net profit ratio, which saw a slight decline to 3.85% this year.

Context metrics

During the year, the company strengthened its balance sheet, as evidenced by a reduction in the Debt-Equity ratio to 0.60 from 0.81 in the prior year. Additionally, the Return on Equity (ROE) saw a notable improvement, climbing to 11.20% compared to 6.03% in FY25.

What to track next

The 13th Annual General Meeting is scheduled for September 25, 2026. Investors should track management’s commentary on how they plan to leverage growth in the food processing, pharmaceutical, and e-commerce segments to offset the identified operational risks.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.